Cherukara M, Shmueli K
MAGMA. 2025; .
PMID: 40024974
DOI: 10.1007/s10334-025-01229-3.
Pishghadam M, Haizler-Cohen L, Ngwa J, Yao W, Kapse K, Iqbal S
Eur Radiol Exp. 2025; 9(1):18.
PMID: 39966316
PMC: 11836258.
DOI: 10.1186/s41747-025-00565-2.
Gao Y, Liang C, Zhang Q, Zhuang H, Sui C, Zhang N
Alzheimers Res Ther. 2025; 17(1):17.
PMID: 39789638
PMC: 11715900.
DOI: 10.1186/s13195-024-01638-x.
Kan H, Nakashima M, Tsuchiya T, Yamada M, Hiwatashi A
Radiol Phys Technol. 2025; 18(1):320-328.
PMID: 39760974
DOI: 10.1007/s12194-024-00878-8.
Zachariou V, Pappas C, Bauer C, Seago E, Gold B
Neurobiol Aging. 2024; 145:1-12.
PMID: 39447489
PMC: 11578767.
DOI: 10.1016/j.neurobiolaging.2024.10.006.
Biophysical contrast sources for magnetic susceptibility and R2* mapping: A combined 7 Tesla, mass spectrometry and electron paramagnetic resonance study.
Otsuka F, Garcia Otaduy M, Rodriguez R, Langkammer C, Oliveira Barbosa J, Salmon C
Neuroimage. 2024; 302:120892.
PMID: 39433113
PMC: 11684258.
DOI: 10.1016/j.neuroimage.2024.120892.
Investigating the relationship between thalamic iron concentration and disease severity in secondary progressive multiple sclerosis using quantitative susceptibility mapping: Cross-sectional analysis from the MS-STAT2 randomised controlled trial.
Williams T, John N, Calvi A, Bianchi A, De Angelis F, Doshi A
Neuroimage Rep. 2024; 4(3):100216.
PMID: 39328985
PMC: 11422291.
DOI: 10.1016/j.ynirp.2024.100216.
Iron changes within infarct tissue in ischemic stroke patients after successful reperfusion quantified using QSM.
Kataike V, Desmond P, Steward C, Mitchell P, Davey C, Yassi N
Neuroradiology. 2024; 66(12):2233-2242.
PMID: 39172165
PMC: 11611990.
DOI: 10.1007/s00234-024-03444-6.
Free-Breathing High-Resolution, Swap-Free, and Motion-Corrected Water/Fat Separation in Pediatric Abdominal MRI.
Nosrati R, Calakli F, Afacan O, Pelkola K, Nichols R, Connaughton P
Invest Radiol. 2024; 59(12):805-812.
PMID: 38857418
PMC: 11560742.
DOI: 10.1097/RLI.0000000000001092.
A comprehensive protocol for quantitative magnetic resonance imaging of the brain at 3 Tesla.
Radunsky D, Solomon C, Stern N, Blumenfeld-Katzir T, Filo S, Mezer A
PLoS One. 2024; 19(5):e0297244.
PMID: 38820354
PMC: 11142522.
DOI: 10.1371/journal.pone.0297244.
Spinet-QSM: model-based deep learning with schatten p-norm regularization for improved quantitative susceptibility mapping.
Venkatesh V, Susan Mathew R, Yalavarthy P
MAGMA. 2024; 37(3):411-427.
PMID: 38598165
DOI: 10.1007/s10334-024-01158-7.
The impact of paramagnetic rim lesions on cortical thickness and gray to white matter contrast in relapsing-remitting multiple sclerosis.
Xie Y, Yao Y, Shen N, Li Y, Zhu H, Lu J
Quant Imaging Med Surg. 2024; 14(3):2614-2626.
PMID: 38545072
PMC: 10963848.
DOI: 10.21037/qims-23-1395.
Quantitative susceptibility mapping for detection of kidney stones, hemorrhage differentiation, and cyst classification in ADPKD.
Schumacher K, Prince M, Blumenfeld J, Rennert H, Hu Z, Dev H
Abdom Radiol (NY). 2024; 49(7):2285-2295.
PMID: 38530430
DOI: 10.1007/s00261-024-04243-6.
Phase-sensitive deep reconstruction method for rapid multiparametric MR fingerprinting and quantitative susceptibility mapping in the brain.
Martinez J, Yu V, Tringale K, Otazo R, Cohen O
Magn Reson Imaging. 2024; 109:147-157.
PMID: 38513790
PMC: 11042874.
DOI: 10.1016/j.mri.2024.03.023.
Technical advances in motion-robust MR thermometry.
Kim K, Narsinh K, Ozhinsky E
Magn Reson Med. 2024; 92(1):15-27.
PMID: 38501903
PMC: 11132643.
DOI: 10.1002/mrm.30057.
Recommended implementation of quantitative susceptibility mapping for clinical research in the brain: A consensus of the ISMRM electro-magnetic tissue properties study group.
Bilgic B, Costagli M, Chan K, Duyn J, Langkammer C, Lee J
Magn Reson Med. 2024; 91(5):1834-1862.
PMID: 38247051
PMC: 10950544.
DOI: 10.1002/mrm.30006.
Maximum spherical mean value filtering for whole-brain QSM.
Roberts A, Romano D, Sisman M, Dimov A, Nguyen T, Kovanlikaya I
Magn Reson Med. 2024; 91(4):1586-1597.
PMID: 38169132
PMC: 11416845.
DOI: 10.1002/mrm.29963.
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling.
Hage S, Kinkade S, Girard R, Flemming K, Kim H, Torbey M
Stroke. 2023; 55(1):31-39.
PMID: 38134265
PMC: 10752356.
DOI: 10.1161/STROKEAHA.123.044083.
Postmortem Brain Imaging in Alzheimer's Disease and Related Dementias: The South Texas Alzheimer's Disease Research Center Repository.
Li K, Rashid T, Li J, Honnorat N, Benet Nirmala A, Fadaee E
J Alzheimers Dis. 2023; 96(3):1267-1283.
PMID: 37955086
PMC: 10693476.
DOI: 10.3233/JAD-230389.
Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson's disease.
Yan S, Lu J, Li Y, Cho J, Zhang S, Zhu W
Eur Radiol. 2023; 34(5):3074-3083.
PMID: 37853173
DOI: 10.1007/s00330-023-10283-1.